Supervised Resistance TRaining amONG Women at Risk of Breast Cancer Related Lymphedema (STRONG-B)
Primary Purpose
Breast Cancer, Physical Activity, Lymphedema of Upper Arm
Status
Recruiting
Phase
Not Applicable
Locations
Chile
Study Type
Interventional
Intervention
Resistance Training
Sponsored by
About this trial
This is an interventional treatment trial for Breast Cancer focused on measuring Resistance training, Quality of life
Eligibility Criteria
Inclusion Criteria:
- Newly diagnosed with stage I-III breast cancer, histologically confirmed.
- Patients scheduled to receive adjuvant post-operative chemotherapy.
- Partial or total mastectomy with axillary node dissection.
- Partial or total mastectomy with sentinel node dissection with body mass index between 30.0 and 39.9 kg/m2.
- Approval of their treating physician to participate in sub-maximal physiological fitness testing and a low to moderate progressive resistance exercise program.
Exclusion Criteria:
- Inter-limb volume difference greater than 200 ml or 10%.
- Previous antineoplastic treatment (chemotherapy, radiotherapy, or endocrine therapy).
- Breast cancer stage IV
- Unable to participate in an exercise program related to other medical problems.
- Be identified as vigorous exercise behavior related to American College of Sports Medicine recommendations.
- Body mass index lower than 18.5 kg/m2 or greater than 40 kg/m2.
- Pregnancy.
- Fluency and understanding of the Spanish language.
Sites / Locations
- Karol RamírezRecruiting
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
No Intervention
Arm Label
Resistance training group
Control Group
Arm Description
Twice a week sessions supervised and group, during 12 weeks
The control group will follow the usual physical therapy management, which does not include resistance training
Outcomes
Primary Outcome Measures
Change from Baseline in Arms lymphedema Volume on the Perometer System at 3, 6 and 9 months.
Perometer is considered the gold standard for determining lymphedema volume in research. Is a valid and reliable tool in volume measurement. It determines volume values expressed in milliliters and percentage. A value of 200 mL or 10% difference between one arm and the other is considered significant.
Change from Baseline in Health-related quality of life on questionnaire: The European Organization for Research and Treatment in Cancer (EORTC) Quality of Life C-30 (QLQ-C30) and breast cancer-specific module QLQ-BR23 at 3, 6, and 9 months.
The QLQ C-30 and specific module QLQ-BR23 are self-administered and validated questionnaires to assess health-related quality of life in patients with breast cancer. Both had been validated in Spanish language and on Chilean population. QLQ-C30 comprises 30 items to assess physical, role, emotional, cognitive, and social functioning. The QLQ-BR23 is a breast-specific module that comprises 23 questions to assess body image, sexual functioning, sexual enjoyment, future perspective, systemic therapy side effects. All scores were linearly transformed to a 0 to 100 scale. A high functional score represents a high or healthy level of functioning. A high QOL is defined by a high score for global health status or QOL. High symptom scores or items represent more severe symptoms or problems.
Secondary Outcome Measures
Change from Baseline in Hand grip strength on Hydraulic Hand Dynamometer at 3, 6 and 9 months.
Dynamometer assess the maximal voluntary grip strength (measured in kilograms). Each subject will perform six trials, three in each arm, with an alternating bilateral sequence. The results will be based on the best punctuation of the three trials, respectively. There are normative values in percentiles for healthy Chilean women.
Change from Baseline in Physical Fitness Six minute walk test at 3, 6 and 9 months.
Six minute walk test is a functional test of sub-maximum cardiorespiratory capacity. Valid and reliable in adults with cancer. Result are expressed in meters. A change of 20-30 meters is considered significant.
Full Information
NCT ID
NCT04821609
First Posted
March 11, 2021
Last Updated
January 10, 2022
Sponsor
Pontificia Universidad Catolica de Chile
Collaborators
Universidad de Granada, National Fund for Research and Development in Health, Chile, Hospital Dr Sotero del Rio
1. Study Identification
Unique Protocol Identification Number
NCT04821609
Brief Title
Supervised Resistance TRaining amONG Women at Risk of Breast Cancer Related Lymphedema
Acronym
STRONG-B
Official Title
"Effect of Supervised Resistance Training on Arm Volume and Quality of Life amONG Women at High Risk for Breast Cancer-related Lymphedema: a Study Protocol for a Randomized Controlled Trial (STRONG-B)"
Study Type
Interventional
2. Study Status
Record Verification Date
December 2021
Overall Recruitment Status
Recruiting
Study Start Date
December 1, 2021 (Actual)
Primary Completion Date
December 2022 (Anticipated)
Study Completion Date
June 2023 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Pontificia Universidad Catolica de Chile
Collaborators
Universidad de Granada, National Fund for Research and Development in Health, Chile, Hospital Dr Sotero del Rio
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
Breast cancer (BC) is the most common neoplasm in Chile, and its medical treatment leads to high survival. One-third of survivors will develop BC-related lymphedema. Lymphedema is a chronic condition characterized by increased volume in the ipsilateral arm to surgery. A higher volume is associated with decreased physical functionality and quality of life. Recent studies suggest that resistance training could control arm volume through increased muscle mass development, improving physical functionality and quality of life for patients. To our knowledge, there is no study that has analyzed the effect of a resistance training program among women at risk of BC-related lymphedema on arm volume and quality of life. The purpose of this study is to determine the effect of resistance training on the arm volume and quality of life among women with adjuvant chemotherapy and high risk of BC-related lymphedema compared to a control group with regular physical therapy management, which does not include resistance training.
This is a randomized controlled study. It will be held at the Complejo Asistencial Dr. Sotero del Río, which receives all patients from the South East Metropolitan Health Service. Participants: 106 women receiving adjuvant chemotherapy for BC who have undergone axillary lymph node dissection or with obesity will be recruited. The difference in volume between the arms will be evaluated with optoelectric equipment. Quality of life with The European Organization for Research and Treatment in Cancer Quality of Life C-30 (EORTC QLQ-C30) and the European Organization for Research and Treatment of Breast Cancer-Specific Quality of Life Questionnaire BR23 (EORTC QLQ-BR23) questionnaires, both validated in Chile; the handgrip with a dynamometer; and physical functionality with the six-minute walk test. Volunteers will be randomly assigned to the resistance training group or control group. The resistance training group will consist of twice a week supervised sessions, for 12 weeks. The exercises will be for arms and legs, self-loading type, and with external weights. The control group will follow the usual physical therapy management, which does not include resistance training. Subsequently, volunteers will be evaluated at the third and sixth months after completion of the 12 weeks resistance training program.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Breast Cancer, Physical Activity, Lymphedema of Upper Arm
Keywords
Resistance training, Quality of life
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantOutcomes Assessor
Allocation
Randomized
Enrollment
106 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Resistance training group
Arm Type
Experimental
Arm Description
Twice a week sessions supervised and group, during 12 weeks
Arm Title
Control Group
Arm Type
No Intervention
Arm Description
The control group will follow the usual physical therapy management, which does not include resistance training
Intervention Type
Behavioral
Intervention Name(s)
Resistance Training
Intervention Description
The resistance training will be for arms and legs, self-loading type, and external weights.
Primary Outcome Measure Information:
Title
Change from Baseline in Arms lymphedema Volume on the Perometer System at 3, 6 and 9 months.
Description
Perometer is considered the gold standard for determining lymphedema volume in research. Is a valid and reliable tool in volume measurement. It determines volume values expressed in milliliters and percentage. A value of 200 mL or 10% difference between one arm and the other is considered significant.
Time Frame
Baseline, 3, 6 and 9 months.
Title
Change from Baseline in Health-related quality of life on questionnaire: The European Organization for Research and Treatment in Cancer (EORTC) Quality of Life C-30 (QLQ-C30) and breast cancer-specific module QLQ-BR23 at 3, 6, and 9 months.
Description
The QLQ C-30 and specific module QLQ-BR23 are self-administered and validated questionnaires to assess health-related quality of life in patients with breast cancer. Both had been validated in Spanish language and on Chilean population. QLQ-C30 comprises 30 items to assess physical, role, emotional, cognitive, and social functioning. The QLQ-BR23 is a breast-specific module that comprises 23 questions to assess body image, sexual functioning, sexual enjoyment, future perspective, systemic therapy side effects. All scores were linearly transformed to a 0 to 100 scale. A high functional score represents a high or healthy level of functioning. A high QOL is defined by a high score for global health status or QOL. High symptom scores or items represent more severe symptoms or problems.
Time Frame
Baseline, 3, 6 and 9 months.
Secondary Outcome Measure Information:
Title
Change from Baseline in Hand grip strength on Hydraulic Hand Dynamometer at 3, 6 and 9 months.
Description
Dynamometer assess the maximal voluntary grip strength (measured in kilograms). Each subject will perform six trials, three in each arm, with an alternating bilateral sequence. The results will be based on the best punctuation of the three trials, respectively. There are normative values in percentiles for healthy Chilean women.
Time Frame
Baseline, 3, 6, and 9 months.
Title
Change from Baseline in Physical Fitness Six minute walk test at 3, 6 and 9 months.
Description
Six minute walk test is a functional test of sub-maximum cardiorespiratory capacity. Valid and reliable in adults with cancer. Result are expressed in meters. A change of 20-30 meters is considered significant.
Time Frame
Baseline and 3, 6 and 9 months.
10. Eligibility
Sex
Female
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
70 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Newly diagnosed with stage I-III breast cancer, histologically confirmed.
Patients scheduled to receive adjuvant post-operative chemotherapy.
Partial or total mastectomy with axillary node dissection.
Partial or total mastectomy with sentinel node dissection with body mass index between 30.0 and 39.9 kg/m2.
Approval of their treating physician to participate in sub-maximal physiological fitness testing and a low to moderate progressive resistance exercise program.
Exclusion Criteria:
Inter-limb volume difference greater than 200 ml or 10%.
Previous antineoplastic treatment (chemotherapy, radiotherapy, or endocrine therapy).
Breast cancer stage IV
Unable to participate in an exercise program related to other medical problems.
Be identified as vigorous exercise behavior related to American College of Sports Medicine recommendations.
Body mass index lower than 18.5 kg/m2 or greater than 40 kg/m2.
Pregnancy.
Fluency and understanding of the Spanish language.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Karol Ramírez, Ph.D (c)
Phone
22 3541168
Email
kramirezp@uc.cl
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Irene Cantarero, Ph.D
Organizational Affiliation
Universidad de Granada
Official's Role
Study Director
First Name & Middle Initial & Last Name & Degree
Karol Ramírez, Ph.D (c)
Organizational Affiliation
Pontificia Universidad Catolica de Chile
Official's Role
Principal Investigator
Facility Information:
Facility Name
Karol Ramírez
City
Puente Alto
State/Province
CO
Country
Chile
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Karol Ramírez
Email
kramirezp@uc.cl
12. IPD Sharing Statement
Citations:
PubMed Identifier
35299753
Citation
Ramirez-Parada K, Lopez-Garzon M, Sanchez-Rojel C, Petric-Guajardo M, Alfaro-Barra M, Fernandez-Verdejo R, Reyes-Ponce A, Merino-Pereira G, Cantarero-Villanueva I. Effect of Supervised Resistance Training on Arm Volume, Quality of Life and Physical Perfomance Among Women at High Risk for Breast Cancer-Related Lymphedema: A Study Protocol for a Randomized Controlled Trial (STRONG-B). Front Oncol. 2022 Mar 1;12:850564. doi: 10.3389/fonc.2022.850564. eCollection 2022.
Results Reference
derived
Learn more about this trial
Supervised Resistance TRaining amONG Women at Risk of Breast Cancer Related Lymphedema
We'll reach out to this number within 24 hrs